|

CD123-CAR T Clinical Trials

1 actively recruiting trial across 1 location

Also known as: CD123-CAR T cells

Pipeline

Phase 1: 1

Top Sponsors

  • St. Jude Children's Research Hospital1

Indications

  • T-ALL1
  • B-ALL1
  • AML/MDS1
  • BPDCN1
  • Cancer1

Memphis, Tennessee1 trial

CD123-Directed T-Cell Therapy for Acute Myelogenous Leukemia (CATCHAML)

St Jude Children's Research Hospital

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.